Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Persistence Pays Off: 2021 Midyear Advocacy Update

Elizabeth (Blair) Solow, MD  |  May 21, 2021

How you can help: Visit the Legislative Action Center to find a pre-populated letter to legislators you can send showing your support for this funding.

Telehealth—Parity & Access
Prior to 2020, telehealth was practiced only by a few providers. Following the extreme drop in patient visits during the public health emergency (PHE), providers quickly learned and implemented telehealth practices to treat patients virtually. The CMS, followed by commercial payers, increased the reimbursement for telehealth to match in-person visits for audio-visual and, later, audio-only visits during the PHE. Several active pieces of legislation moving through Congress and in various states would expand access to telehealth beyond the PHE.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

How you can help: Watch for a call to action to send letters to Congress, the administration and state legislators to continue to expand telehealth flexibility and ensure appropriate reimbursement.

Utilization Management & Reimbursement
Step therapy bills have been re-introduced in both the House (H.R. 2163) and the Senate (S. 464). This legislation requires Employee Retirement Income Security Act (ERISA) health plans to allow for reasonable overrides so physicians can use certain medications, helping relieve the burden placed on providers and patients.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

We are awaiting re-introduction of bills on prior authorization and dual-energy X-ray absorptiometry (DXA) reimbursement, which had strong bipartisan support in the past Congress. The prior authorization legislation will protect patients in Medicare Advantage plans that delay or deny access to care. It also supports reporting back to the CMS how often Medicare Advantage plans approve or deny medications and services.

Additionally, we have seen some wins early in the state legislative year. Arkansas has passed step therapy reform, and Georgia has sent prior authorization reform to the governor. Utilization management reform legislation is on the move in California, Arizona, Oregon and Texas, while several other states have introduced bills that we are supporting. We expect additional wins as the year progresses.

How you can help: The Legislative Action Center contains pre-written letters urging utilization management reform.

Up Next
This May, we (virtually) visited Washington, D.C., to advocate for workforce expansion, step therapy legislation and provider solvency as we continue to practice during a pandemic. We are tracking a number of issues and would love to hear from you. Check out the ACR’s advocacy priorities and join us for a Hill Day in September. I look forward to having conversations with you about how advocacy and health policy affect your patients and your practice.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:Legislation & Advocacy Tagged with:Blair SolowGovernment Affairs Committee (GAC)

Related Articles

    ACR Advocacy: 2021 Midyear Update

    June 13, 2021

    Beginning in the late 1800s, Eliza Ruhamah Scidmore, U.S. diplomat and writer, spent 24 years advocating for sakura, or Japanese cherry trees, to be planted in Washington, D.C. After unsuccessfully petitioning every U.S. Army Superintendent of Public Buildings and Grounds for over two decades, she wrote a letter to First Lady Helen Herron Taft about…

    The ACR’s 2020 Advocacy Year in Review

    February 16, 2021

    To say it has been an interesting (the science and the memes), tumultuous (the politics) and heartbreaking (the pandemic and social injustice) year is an understatement. There have been moments of grace and inspiration that we hope have kept everyone going.  As we look to 2021, we take lessons from our experiences in 2020. Washington,…

    ACR Advocacy: 2020 Year in Review

    January 11, 2021

    As a new year begins, Government Affairs Committee Chair Blair Solow, MD, takes stock of ACR advocacy wins in 2020 and issues to watch in 2021, including workforce issues, continued telemedicine access, prior authorization relief, Medicare reimbursement and drug pricing.

    The Power of Advocacy

    January 10, 2022

    In 1916, a handful of conservation advocates successfully lobbied Congress to create the National Park Service, which now protects more than 85 million acres of U.S. land. Dedicated rheumatology advocacy has lasting effects, too, as evidenced by several policy wins in 2021 and efforts underway for 2022.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences